| Welcome to the Lancashire and South Cumbria ICB Formulary This formulary was developed with primary and secondary care clinicians with the aim of harmonising and consolidating the existing local formularies used within the region.
Please note that while some chapters have been fully reviewed by clinical groups, others were drafted in collaboration with the Formulary Working Group and have been reviewed via a consultation exercise so may be subject to change when fully reviewed. See ‘news feed’ below for more information. |
Useful Links
|
| News Feed |
|
December 2024:
19.12.24 - Please find below the link to download the latest change log documenting any recent formulary changes.
LSCMMG/Netformulary change log Dec 24 V1
|
|
November 2024:
28.11.24 - Please find below the link to download the latest change log documenting any recent formulary changes.
LSCMMG/Netformulary change log Nov 24 V1.1
|
|
November 2024:
Malignant disease and immunosuppression chapter is now live.
|
|
November 2024:
22.11.24 - Please find below the link to download the latest change log documenting any recent formulary changes.
LSCMMG/Netformulary change log Nov 24
|
|
November 2024:
Immunological products and vaccines chapter is now live.
|
|
November 2024:
Anaesthesia chapter now live.
|
| >>> more news |
|
|
The Lancashire and South Cumbria Medicines Management Group has formed a Lancashire and South Cumbria Formulary Group (known as the ‘Formulary Group’) and is undertaking to combine the following legacy Lancashire formularies to produce a single Lancashire and South Cumbria ICB formulary:
The formulary development team can be contacted here: mlcsu.lscformulary@nhs.net
|
|
|
|
